Jan 9Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery PlatformsRNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human...
Jan 6eFFECTOR Therapeutics Provides Positive Clinical Data Update for ZotatifinZotatifin continues to show favorable activity profile, including two confirmed partial responses (PR) among seven heavily pretreated...